| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |